Search in the Abstract Database

Search Abstracts 2016

* = Presenting author

N004 Faecal Incontinence in inflammatory bowel disease and its association with anxiety and depression in an Irish tertiary centre

A. Keogh*

University Hospital Galway, Galway, Ireland

Background

Aims:

1.To investigate an association between Faecal Incontinence (FI) and anxiety and depression in patients with Inflammatory Bowel Disease (IBD).

2.To estimate the prevalence of anxiety and depression in patients with IBD.

3.To estimate the prevalence of FI in patients with IBD.

4.To observe if patients have higher levels of anxiety and depression with FI than patients without FI in IBD.

Methods

A postal survey was sent to a cross section of 250 patients with IBD attending a tertiary referral centre. Basic demographics, medical information, Hospital Anxiety and Depression Score (HADS), Harvey–Bradshaw Index (HBI), Walmsley Index, and a section of the International Consultation on Incontinence Questionnaire-Inflammatory Bowel disease (ICIQ-IBD) were collected.

Results

From 250 surveys sent, 117 (46.8%) responses were received, with Crohn’s disease (CD) patients 60.7% (n = 71) and ulcerative colitis (UC) 39.3% (n = 46). Further, 56% of respondents were female, and 44% were male. Respondents had a mean age of 49 years and 17 years disease duration. In addition, 70% of respondents had at least one episode of FI in the last 3 months; 52.1% of respondents experienced anxiety; and 31.3% of respondents experienced depression. A positive association was found amongst anxiety (p < 0.001), depression (p = 0.005), and FI in patients with IBD. Diagnosis, age, disease duration, and gender were not found to be significantly associated with FI.

Conclusion

Faecal incontinence is associated with anxiety and depression in IBD. Higher levels of anxiety and depression were found in patients with IBD and FI. Appropriate assessment of FI could aid identification of patients at risk of higher levels of anxiety and depression. The psychological needs of patients must be addressed to help improve patient outcomes. Healthcare professionals need to actively enquire about FI in IBD.